Silence Therapeutics reported $185.47K in Gross Profit on Sales for its fiscal quarter ending in June of 2025.





Gross Profit On Sales Change Date
AstraZeneca USD 12.86B 251M Jun/2026
Autolus Therapeutics Ltd USD 1.65M 2.69M Mar/2026
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Novartis USD 11.24B 1.18B Jun/2026
Roche Holding CHF 22.69B 600M Jun/2026
Silence Therapeutics USD 185.47K 1.82M Jun/2025